title: "B" for Bad, Beneficial, or Both? Lung Lymphoid Neogenesis in Chronic Obstructive Pulmonary Disease.
authors.affiliation: 1 Pulmonary and Critical Care Medicine Section VA Ann Arbor Healthcare System Ann Arbor, Michigan and.|2 Division of Pulmonary and Critical Care Medicine and.|3 Graduate Program in Immunology University of Michigan Health System Ann Arbor, Michigan.
authors.forename: Jeffrey L
authors.identifier: http://orcid.org/0000-0001-5191-4847
authors.initials: JL
authors.lastname: Curtis
authors.affiliation: 4 Division of Pulmonary and Critical Care Medicine University of Michigan Health System Ann Arbor, Michigan and.|5 Research Service VA Ann Arbor Healthcare System Ann Arbor, Michigan.
authors.forename: Christine M
authors.initials: CM
authors.lastname: Freeman
authors.affiliation: 2 Division of Pulmonary and Critical Care Medicine and.|6 Department of Microbiology & Immunology University of Michigan Health System Ann Arbor.
authors.forename: Gary B
authors.initials: GB
authors.lastname: Huffnagle
mesh_terms: D056704:Adaptive Immunity; D000818:Animals; D053264:B-Cell Activating Factor / Q000276:immunology* / Q000378:metabolism*; D001402:B-Lymphocytes / Q000276:immunology*; D005260:Female; D006801:Humans; D008168:Lung / Q000378:metabolism*; D008221:Lymphoid Tissue / Q000276:immunology*; D008297:Male; D029424:Pulmonary Disease, Chronic Obstructive / Q000276:immunology* / Q000378:metabolism*
chemical_list: D053264:B-Cell Activating Factor; C505719:TNFSF13B protein, human